Ever dream of a stock that skyrockets overnight? That’s what happened with Abivax, a French biotech company. Thanks to rumors that pharma giant Eli Lilly might buy them, Abivax shares shot up over 11% in a day—and a jaw-dropping 1,800% this year! The buzz? Abivax’s new ulcerative colitis drug is showing big promise. If you’re into biotech, this is one to watch—just remember, rumors can make stocks wild! #Business #Market #stocks